Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB vs UBLITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB vs UBLITUXIMAB: Safety Overview

Metric RITUXIMAB UBLITUXIMAB
Total FAERS Reports 178,614 1,582
Deaths Reported 28,910 27
Death Rate 16.2% 1.7%
Hospitalizations 54,631 213
Average Patient Age 54.6 yrs 49.7 yrs
% Female Patients 64.3% 73.4%
Manufacturer Genentech, Inc. TG Therapeutics, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A